换一批
换一批Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.
第一作者：
F,Giuliano
第一单位：
AP-HP, Neuro-Uro-Andrology, Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, Garches, France. giuliano@cyber-sante.org
作者：
主题词
老年人(Aged);心血管疾病(Cardiovascular Diseases);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);药物相互作用(Drug Interactions);勃起功能障碍(Erectile Dysfunction);听力障碍(Hearing Disorders);人类(Humans);肾疾病(Kidney Diseases);肝疾病(Liver Diseases);男(雄)性(Male);中年人(Middle Aged);磷酸二酯酶抑制剂(Phosphodiesterase Inhibitors);哌嗪类(Piperazines);阴茎异常勃起(Priapism);产品监测, 售后(Product Surveillance, Postmarketing);嘌呤类(Purines);随机对照试验(主题)(Randomized Controlled Trials as Topic);砜类(Sulfones);治疗结果(Treatment Outcome)
DOI
10.1111/j.1742-1241.2009.02254.x
PMID
19900167
发布时间
2021-10-20
- 浏览23
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
